FrancophonIA/ELRC3.0 huggingface dataset:
English: The requirement for submission of periodic safety update report for this medicinal product are set out in the line of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2011/83/EC and any subsequent updates published on the European medicines web-portal.
Croatian: • Periodička izvješća o neškodljivosti Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7.
English: For an administered activity of 360 MBq the typical radiation doses delivered to the critical organs, gallbladder, urinary bladder, upper large intestine wall, lower large intestine wall, small intestine and liver are 49.3 mGy, 25.0 mGy, 13.8 mGy, 12.6 mGy, 11.3 mGy and 13.9 mGy, respectively.
Croatian: 49,3 mGy za žučni mjehur, 25,0 mGy za mokraćni mjehur, 13,8 za stijenku gornjeg dijela debelog crijeva, 12,6 mGy za stijenku donjeg dijela debelog crijeva, 11,3 mGy za tanko crijevo i 13,9 mGy za jetru.
English: It is unknown whether florbetaben (18F) is excreted in human milk.
Croatian: Nije poznato izlučuje li se florbetaben (18F) u majčino mlijeko.
English: Package leaflet: Information for the patient Neuraceq 300 MBq/mL solution for injection florbetaben (18F)
Croatian: Uputa o lijeku: Informacije za bolesnika Neuraceq 300 MBq/ml otopina za injekciju florbetaben (18F)
English: You must stop breast-feeding for 24 hours after the injection.
Croatian: Ne smijete dojiti tijekom 24 sata nakon injekcije.
English: The pharmacokinetics of florbetaben (18F) in patients with renal or hepatic impairment has not been characterised.
Croatian: Farmakokinetika florbetabena (18F) u bolesnika s oštećenom funkcijom bubrega ili jetre nije opisana.
English: LEAD POT (without Blue Box)
Croatian: OLOVNI SPREMNIK (bez plavog okvira)
English: Any unused material should be disposed of in accordance with national regulations.
Croatian: Neiskorišteni materijal potrebno je zbrinuti sukladno nacionalnim propisima.
English: Injection site pain Injection/application site erythema
Croatian: Bol na mjestu injiciranja Eritem na mjestu primjene /primjene
English: Neuraceq images should only be interpreted by readers trained in the interpretation of PET images with florbetaben (18F).
Croatian: Slike dobivene uz primjenu Neuraceqa trebaju tumačiti samo osobe obučene za tumačenje slika dobivenih PET-om uz primjenu florbetabena (18F).
English: Cis Bio International 14 rue de la Grange aux Belles 75010 Paris
Croatian: Cis Bio International 14 rue de la Grang aux Belles 75010 Pariz
English: Each mL of solution for injection contains 300 MBq of florbetaben (18F) at the date and time of calibration.
Croatian: Jedan ml otopine za injekciju sadrži 300 MBq florbetabena (18F) na dan i sat kalibriranja.
English: At the 24-month follow-up, 19 (42.2%) converted to clinical AD. Of the 29 MCI subjects who had a positive PET scan, 19 (65.5%) were classified clinically as converted to clinical AD after 24 months compared to 0 (0%) of 16 who had a negative scan.
Croatian: Od 29 bolesnika s blagim oštećenjem kognitivne funkcije u kojih je nalaz PET oslikavanja bio pozitivan, 24 mjeseca kasnije je klinički dijagnosticirana Alzheimerova bolest u njih 19 (65,5%), u usporedbi s 0 (0%) takve dijagnoze od 16 bolesnika s negativnim nalazom PET oslikavanja.
English: No fertility studies have been performed.
Croatian: Plodnost Nisu provedena ispitivanja plodnosti.
English: Remaining organs
Croatian: Maternica Ostali organi
English: Table 2: Definitions of brain amyloid plaque load (BAPL) Assessment
Croatian: Tablica 2: Definicije opterećenja moždanog tkiva amiloidnim plakovima Procjena
English: injection site haematoma (a bruise, a black and blue mark at injection site), injection site warmth, tiredness, feeling hot, pyrexia (raised body temperature, a fever) - Abnormal blood test: increased blood creatinine levels (reduced kidney function)
Croatian: - Promjene na mjestu injekcije: nadraženost na mjestu primjene injekcije, bol i nelagoda oko mjesta injekcije, hematom na mjestu injekcije (modrice, crni i plavi tragovi na mjestu injekcije), toplina na mjestu injekcije, umor, osjećaj vrućine, vrućica (povišena tjelesna temperatura) - Poremećeni rezultati krvnih pretraga: povišene razine kreatinina u krvi (smanjena funkcija bubrega)
English: - Do not use after the expiry date which is stated on the box, shield label and vial label after
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji, naljepnici zaštitnog spremnika i naljepnici bočice iza oznake Rok valjanosti.
English: Positive scan
Croatian: Pozitivan nalaz
English: Neuraceq contains the active substance florbetaben (18F).
Croatian: Neuraceq sadrži djelatnu tvar florbetaben (18F).
English: Method of administration Neuraceq is for intravenous use and for multidose use.
Croatian: Neuraceq je namijenjen za intravensku primjenu i za višedoznu primjenu.
English: The design of this study does not allow estimating the risk of MCI progression to clinical AD.
Croatian: Ustroj navedenog ispitivanja ne omogućuje procjenu rizika progresije blagog oštećenja kognitivne funkcije u simptomatsku
English: Neuraceq 300 MBq/mL solution for injection florbetaben (18F)
Croatian: Neuraceq 300 MBq/ml otopina za injekciju florbetaben (18F)
English: Curium Pharma Spain, S.A. Pol. Ind. Conpisa, C/ Veguillas - 2 Nave 16, Ajalvir 28864 (Madrid) Spain
Croatian: Pol. Ind. Conpisa, C / Veguillas - 2 Nave 16, Ajalvir 28864 (Madrid) Španjolska
English: 2 (Moderate tracer uptake)
Croatian: 2 (Umjereni unos obilježivača)
English: Each multidose vial contains 1 to 10 mL of solution, corresponding to 300 to 3000 MBq at the date and time of calibration (ToC).
Croatian: Jedna višedozna bočica sadrži 1 do 10 ml otopine, što odgovara 300 do 3000 MBq na dan i sat kalibriranja (ToC).
English: Neuraceq 300 MBq/mL solution for injection
Croatian: Neuraceq 300 MBq/ml otopina za injekciju
English: The injection of florbetaben (18F) must be intravenous in order to avoid irradiation as a result of local extravasation, as well as imaging artefacts.
Croatian: Florbetaben (18F) se mora injicirati intravenski kako bi izbjegli ozračivanje zbog lokalne ekstravazacije i pojavu artefakata na slikama.
English: Reducing head movement with tape or other flexible head restraints may be employed.
Croatian: Pomicanje glave može se smanjiti ako se glava imobilizira trakom ili nekim drugim elastičnim pomagalom.
English: What you need to know before Neuraceq is used Neuraceq must not be used:
Croatian: Što morate znati prije primjene Neuraceqa Nemojte primjenjivati Neuraceq
English: The activity of florbetaben (18F) has to be measured with an activimeter (dose calibrator) immediately prior to injection.
Croatian: Aktivnost florbetabena (18F) potrebno je izmjeriti mjeračem aktivnosti (kalibratorom doze)
English: Each multidose vial contains 1 to 10 mL of solution, corresponding to 300 to 3000 MBq of florbetaben (18F) at the date and time of calibration.
Croatian: Jedna višedozna bočica sadrži 1 do 10 ml otopine, što odgovara 300 do 3000 MBq florbetabena (18F) na dan i sat kalibriranja.
English: 3 (Pronounced tracer uptake)
Croatian: 3 (Izraženi unos obilježivača)
English: Resuming breast-feeding should be in agreement with the nuclear medicine doctor who will supervise the procedure.
Croatian: Nastavak dojenja mora odobriti specijalist nuklearne medicine koji nadzire postupak.
English: Patients should be supine with the head positioned to centre the brain, including the cerebellum, in the PET scanner field of view.
Croatian: Bolesnici moraju ležati na leđima, glave položene na način da se mozak, uključujući mali mozak,
English: The highest level of uptake is in pons and other white matter regions.
Croatian: Najveće nakupljanje primijećeno je u ponsu i bijeloj tvari.
English: Condition for assessment
Croatian: Stanje za procjenu
English: If a CT scan is simultaneously performed as part of the PET procedure, exposure to ionising radiation will increase in an amount dependent on the settings used in the CT acquisition.
Croatian: pretrage, izloženost ionizirajućem zračenju povećat će se u mjeri koja ovisi o postavkama primijenjenima za CT oslikavanje.
English: The volume of Neuraceq to be injected can be from 0.5 to 10 mL in order to provide the target activity of 300 MBq at the time of intravenous administration.
Croatian: U vrijeme primjene maksimalna doza ne smije biti viša od 360 MBq i niža od 240 MBq.Volumen injekcije Neuraceqa može biti od 0,5 do 10 ml kako bi se osigurala ciljna aktivnost od 300 MBq u vrijeme intravenske primjene.
English: Close contact with infants and pregnant women should be restricted during the initial 24 hours following the injection.
Croatian: Potrebno je ograničiti blizak kontakt s dojenčadi i trudnicama tijekom prvih 24 sata nakon injekcije.
English: Ascorbic acid, ethanol anhydrous, macrogol 400, sodium ascorbate (for pH adjustment), water for injections
Croatian: Askorbatna kiselina, bezvodni etanol, makrogol 400, natrijev askorbat (za podešavanje pH), voda za injekcije
English: The activity per vial ranges from 300 MBq to 3000 MBq at the date and time of calibration.
Croatian: Aktivnost po bočici je u rasponu od 300 MBq do 3000 MBq na dan i sat kalibriranja.
English: How Neuraceq will be used
Croatian: Kako se primjenjuje Neuraceq
English: Close contact with infants should be restricted during the initial 24 hours following injection.
Croatian: Potrebno je ograničiti blizak kontakt s dojenčadi tijekom prvih 24 sata nakon injekcije.
English: In a post-hoc analysis sensitivity and specificity of the majority read of the visual subject-level PET reading vs histopathology in a larger population (74 patients) was 97.9% (95% CI: 93.8 - 100%) and 88.9% (95% CI: 77-100%).
Croatian: PET-a naspram histopatologije u većoj populaciji (74 bolesnika) iznosila je 97,9% (95% CI: 93,8100%) i 88,9% (95% CI: 77-100%).
English: One multi-dose vial
Croatian: Jedna višedozna bočica
English: Diarrhoea Nausea
Croatian: Alzheimerovu bolest.
English: If you have any further questions on the use of this medicine, please ask your nuclear medicine doctor who supervises the procedure.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom lijeka, obratite se liječniku specijalistu nuklearne medicine koji nadgleda postupak.
English: How Neuraceq is stored
Croatian: Kako čuvati Neuraceq
English: Hepatic function abnormal
Croatian: Poremećaji jetre i žuči abnormalna funkcija jetre
English: via Pergolesi, 33
Croatian: IBA Molecular Italy S.R.L. via Pergolesi, 33
English: 2 Scan with moderate beta-amyloid deposition
Croatian: 2 Slika s beta-amiloidnim depozitom umjerene gustoće
English: Pack size: one vial
Croatian: Veličina pakiranja: jedna bočica.
English: Renal/hepatic impairment The pharmacokinetics in patients with renal or hepatic impairment has not been characterised.
Croatian: Farmakokinetika u bolesnika s oštećenjem funkcije bubrega ili jetre nije opisana.
English: - The active substance is florbetaben (18F).
Croatian: - Djelatna tvar je florbetaben (18F).
English: Negative scan
Croatian: Negativan nalaz
English: Life Radiopharma Bonn GmbH, Germany IBA Molecular Italy S.R.L., Monza, Italy IBA Molecular Italy S.R.L., Rome, Italy IBA Molecular Italy S.R.L., Udine, Italy Curium Pharma Spain, S.A., Seville, Spain Curium Pharma Spain, S.A., Madrid, Spain Seibersdorf Labor GmbH, Austria BetaPlus Pharma SA, Brussels, Belgium Institut Radiofarmacia Aplicada Barcelona-IRAB, Barcelona, Spain
Croatian: Life Radiopharma Bonn GmbH, Njemačka IBA Molecular Italy S.R.L., Monza, Italija IBA Molecular Italy S.R.L., Rome, Italija IBA Molecular Italy S.R.L., Udine, Italija Curium Pharma Spain, S.A., Seville, Španjolska Curium Pharma Spain, S.A., Madrid, Španjolska Seibersdorf Labor GmbH, Austrija
English: Alliance Medical Radiopharmacy Ltd., UK BV Cyclotron VU, the Netherlands Cis Bio International, Nancy, France Cis Bio International, Nîmes, France Cis Bio International, Paris, France Cis Bio International, Rennes, France Cis Bio International, Pessac, France Life Radiopharma Berlin GmbH, Germany Advanced Accelerator Applications Germany GmbH, Germany Life RadiopharmaWarszawa Sp. z o.o., Poland
Croatian: Cis Bio International, Nancy, Francuska Cis Bio International, Nîmes, Francuska Cis Bio International, Pariz, Francuska Cis Bio International, Rennes, Francuska Cis Bio International, Pessac, Francuska Life Radiopharma Berlin GmbH, Njemačka Advanced Accelerator Applications Germany GmbH, Njemačka Life Radiopharma Warszawa Sp. z o.o., Poljska
English: Upper large intestine Heart
Croatian: Gornji dio debelog crijeva
English: • Information on amyloid pathology in Alzheimer's disease;
Croatian: • Podatke o patologiji nakupljanja amiloida u Alzheimerovoj bolesti; • Značajne informacije o Neuracequ kao obilježivaču β-amiloida pri snimanju PET-om,
English: Thymus
Croatian: Zamor
English: 3 Scan with pronounced beta-amyloid deposition
Croatian: 3 Slika s beta-amiloidnim depozitom izrazite gustoće
English: It is supplied in a colourless 15 mL glass vial, sealed with a rubber stopper and aluminium seal.
Croatian: Dolazi se u bezbojnoj staklenoj bočici od 15 ml,
English: Ascorbic acid, ethanol anhydrous, macrogol 400, sodium ascorbate, water for injections.
Croatian: Askorbatna kiselina, bezvodni etanol, makrogol 400, natrijev askorbat, voda za injekcije Vidjeti uputu o lijeku za dodatne informacije.
English: - If you get any side effects, talk to your nuclear medicine doctor.
Croatian: - Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti vašeg liječnika specijalista nuklearne medicine.
English: The in vivo binding of florbetaben (18F) to other amyloid structures or other brain structures or receptors remains unknown.
Croatian: In vivo nije u bolesnika u terminalnoj fazi bolesti procijenjena kvantitativna korelacija između nakupljanja florbetabena (18F) u kortikalnoj sivoj tvari i depozita β-amiloida u uzorcima dobivenih obdukcijom.Vezivanje florbetabena (18F) za druge amiloidne strukture te druge moždane strukture ili receptore u mozgu in vivo i dalje je nepoznato.
English: A recent co-registered computed tomography (CT) scan or magnetic resonance (MR) imaging of the patient to get a fused PET-CT or PET-MR image is recommended in cases of uncertainty about the location of grey matter and of the grey/white matter border in the PET scan (see section 4.4).
Croatian: Ako se na slikama dobivenim PET-om ne može sa sigurnošću lokalizirati siva tvar te odrediti granica između sive i bijele tvari, preporučuje se slike dobivene PET-om fuzionirati s nedavno učinjenom slikom kompjuterizirane tomografije (CT) ili magnetske rezonancije (MR) kako bi se dobila kombinirana slika PET-CT ili PET-MR (vidjeti dio
English: Marketing Authorization Holder
Croatian: Nositelj odobrenja za stavljanje lijeka u promet
English: Multidose.
Croatian: Višedozno.
English: If you get any side effects please talk to your nuclear medicine doctor.
Croatian: Ako primijetite bilo koju nuspojavu, potrebno je obavijestiti vašeg liječnika specijalista nuklearne medicine.
English: Vessel puncture site pain Catheter site pain Injection site haematoma Injection site irritation Puncture site reaction Injection site discomfort Injection site warmth
Croatian: Bol na mjestu uboda žile Bol na mjestu katetera Hematom na mjestu injiciranja Iritacija na mjestu primjene injekcije
English: Please refer to the SmPC {SmPC should be included in the box}.
Croatian: Pročitajte sažetak opisa svojstava lijeka {sažetak opisa svojstava lijeka mora biti priložen u kutiji}.
English: Small intestine
Croatian: Srce Bubrezi
English: In all 31 subjects, a blinded visual subject-level PET reading by 3 blinded readers resulted in a majority read sensitivity of 100% (95% CI: 80.5-100%) and specificity 85.7% (95% CI: 67.4 - 100%).
Croatian: dijagnostičara većinom pokazalo osjetljivost tumačenja od 100% (95% CI: 80,5-100%) i specifičnost 85,7% (95% CI: 67,4-100%).U post-hoc analizi osjetljivosti i specifičnosti većine tumačenja nalaza
English: Neuralgia Headache Burning sensation Tremor
Croatian: Neuralgija Glavobolja
English: The potential toxicity of 28 days of repeated intravenous injections of florbetaben (18F) was tested in rats and dogs, and the NOAEL was found to be at least 20 times the maximum human dose.
Croatian: dana ispitana je na štakorima i psima, pri čemu je utvrđeno da je razina izloženosti pri kojoj nisu opaženi štetni učinci (engl., No-observed-adverse-effect level, NOAEL) najmanje 20 puta veća od najveće doze u ljudi.
English: Radiation protection precautions in accordance with national regulations must therefore be taken.
Croatian: Radiofarmaceutike je potrebno čuvati u skladu s nacionalnim propisima o radioaktivnim materijalima.
English: Breasts
Croatian: Proljev
English: The following information is intended for the specialist only: - Keep out of the sight and reach of children.
Croatian: Sljedeće informacije namijenjene su samo liječniku specijalisti:
English: Alliance Medical Radiopharmacy Ltd., UK BV Cyclotron VU, the Netherlands Cis Bio International, Nancy, France Cis Bio International, Nîmes, France Cis Bio International, Paris, France Cis Bio International, Rennes, France Cis Bio International, Pessac, France Life Radiopharma Berlin GmbH, Germany Advanced Accelerator Applications Germany GmbH, Germany Life Radiopharma Warszawa Sp. z o.o., Poland Life Radiopharma Bonn GmbH, Germany IBA Molecular Italy S.R.L., Monza, Italy IBA Molecular Italy S.R.L., Rome, Italy IBA Molecular Italy S.R.L., Udine, Italy Curium Pharma Spain, S.A., Seville, Spain Curium Pharma Spain, S.A., Madrid, Spain Seibersdorf Labor GmbH, Austria BetaPlus Pharma SA, Brussels, Belgium Institut Radiofarmacia Aplicada Barcelona-IRAB, Barcelona, Spain
Croatian: Advanced Accelerator Applications Germany GmbH, Njemačka Life Radiopharma Warszawa Sp. z o.o., Poljska Life Radiopharma Bonn GmbH, Njemačka IBA Molecular Italy S.R.L., Monza, Italija IBA Molecular Italy S.R.L., Rome, Italija IBA Molecular Italy S.R.L., Udine, Italija Curium Pharma Spain, S.A., Seville, Španjolska Curium Pharma Spain, S.A., Madrid, Španjolska Seibersdorf Labor GmbH, Austrija
English: Bladder
Croatian: Gušterača
English: Muscles
Croatian: Pluća Mišići
English: Lower large intestine
Croatian: Nadbubrežna žlijezda Mozak
English: Lot
Croatian: Timus
English: It is available as:
Croatian: Dostupan je kao:
English: The medicines are normally given shortly before a meal, but can be given just after a meal if necessary.
Croatian: Lijekovi se obično daju neposredno prije obroka, ali se mogu dati i nakon obroka ako je potrebno.
English: Further information on NovoMix can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/novomix.
Croatian: Više informacija o lijeku NovoMix dostupno je na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/novomix.
English: NovoMix (insulin aspart)
Croatian: NovoMix (aspart inzulin)
English: What is NovoMix and what is it used for?
Croatian: Što je NovoMix i za što se koristi?
English: NovoMix 50 and NovoMix 70 can only be used in adults (from 18 years of age).
Croatian: NovoMix 50 i NovoMix 70 smiju se koristiti samo u odraslih osoba (od 18 godina i više).
English: What measures are being taken to ensure the safe and effective use of NovoMix?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka NovoMix?
English: Other information about NovoMix
Croatian: Ostale informacije o lijeku NovoMix
English: NovoMix received a marketing authorisation valid throughout the EU on 1 August 2000.
Croatian: Lijek NovoMix dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 1. kolovoza 2000.
English: Patients can inject themselves with NovoMix once they have been trained appropriately.
Croatian: Bolesnici si mogu sami ubrizgati lijek NovoMix nakon što prođu odgovarajuću obuku.
English: The medicines are given by injection under the skin of the abdomen (belly), thigh, upper arm or buttock.
Croatian: Lijekovi se daju injekcijom pod kožu abdomena (trbuha), bedra, nadlaktice ili stražnjice.
English: The European Medicines Agency decided that NovoMix's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka NovoMix nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: By restoring the effects of insulin, the level of blood glucose is controlled better and the symptoms and complications of diabetes are reduced.
Croatian: Ponovnim postizanjem učinka inzulina razina glukoze u krvi bolje se kontrolira, a simptomi i komplikacije šećerne bolesti se smanjuju.
English: NovoMix is a replacement insulin.
Croatian: NovoMix je zamjenski inzulin.
English: Side effects reported with NovoMix are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek NovoMix pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of NovoMix have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka NovoMix nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: NovoMix medicines can only be obtained with a prescription and are available in cartridges and prefilled pens.
Croatian: Lijekovi NovoMix izdaju se samo na recept i dostupni su u ulošcima i napunjenim brizgalicama.
English: NovoMix 30 can be used in patients from 10 years of age.
Croatian: NovoMix 30 smije se koristiti u bolesnika u dobi od deset i više godina.
English: As for all medicines, data on the use of NovoMix are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka NovoMix kontinuirano se prate.
English: For more information about using NovoMix, see the package leaflet or contact your doctor or pharmacist.
Croatian: Za više informacija o primjeni lijeka NovoMix pročitajte uputu o lijeku odnosno obratite se liječniku ili ljekarniku.
English: Diabetes is a disease in which the body does not produce enough insulin or is not able to use insulin effectively, resulting in raised levels of glucose in the blood.
Croatian: Šećerna bolest je bolest kod koje tijelo ne proizvodi dovoljno inzulina ili ga ne može učinkovito koristiti što rezultira povišenom razinom glukoze u krvi.
English: In type 2 diabetes, NovoMix can be given on its own or together with other diabetes medicines.
Croatian: U bolesnika sa šećernom bolešću tipa 2 lijek NovoMix se može primjenjivati sam ili u kombinaciji s drugim lijekovima protiv šećerne bolesti.
English: An overview of NovoMix and why it is authorised in the EU
Croatian: Pregled informacija o lijeku NovoMix i zašto je odobren u EU-u
English: What are the risks associated with NovoMix?
Croatian: Koji su rizici povezani s lijekom NovoMix?
English: In 5 studies involving a total of around 1,350 patients with type 2 diabetes, adding NovoMix medicines to other diabetes medicines (metformin, sulphonylureas, pioglitazone and liraglutide) also resulted in better control of blood glucose than the other medicines or NovoMix used alone.
Croatian: U 5 ispitivanja koja su obuhvaćala otprilike 1 350 bolesnika sa šećernom bolešću tipa 2 uvođenje lijeka NovoMix u kombinaciji s drugim lijekovima za šećernu bolest (metformin, sulfonilureja, pioglitazon i liraglutid) rezultiralo je boljom kontrolom glukoze u krvi nego kada su se NovoMix i ostali lijekovi primjenjivali zasebno.